Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Creative biolabs has developed Lentiviral CAR vector pCDCAR1 GLP1R (X9X147) h(28BB_), which is constructed for the engineering of T cells to target human GLP1R. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-GLP1R antibody linked to a CD28 transmembrane domain/ endodomain and CD137 (4-1BB), CD3-zeta signaling domains. And the vector product was designed for the treatment of Type 2 diabetes.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.